VolitionRX
VNRX
VNRX
17 hedge funds and large institutions have $18.8M invested in VolitionRX in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$41K |
| 2 |
2
Northern Trust
Chicago,
Illinois
|
$91K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$14K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$824K |
| 5 |
5
Bank of New York Mellon
New York
|
$45K |
Top Sellers
| 1 |
LIM
1
Lagoda Investment Management
New York
|
$11.8M |
| 2 |
AIM
2
Acrospire Investment Management
Chicago,
Illinois
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$237K |
| 4 |
4
Creative Planning
Overland Park,
Kansas
|
$53K |
